慢性肾脏病的诊断与分期:立足循证,审慎批判,稳健发展
被引量:4
摘要
2002年美国肾脏病基金会肾脏病患者生存质量指导(K/DOQI)专家组首次正式提出慢性肾脏病(CKD)的概念。随后在2004年全球提高肾脏病预后组织(KDIGO)经过讨论肯定了K/DOQI关于CKD的定义与分期,并进行了修订和推广。
出处
《中华内科杂志》
CAS
CSCD
北大核心
2009年第12期992-994,共3页
Chinese Journal of Internal Medicine
参考文献13
-
1National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease : evaluation, classification, and stratification. Am J Kidney Dis, 2002,39 : S1-S266.
-
2Levey AS, Eckardt KU, Tsukamoto Y, et al. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int, 2005, 67:2089-2100.
-
3Herget-Rosenthal S, Bokenkamp A, Hofmann W. How to estimate GFR-serum creatinine, serum cystatin C or equations? Clin Biochem, 2007, 40 : 153-161.
-
4L Levey AS, Stevens A, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med, 2009, 150: 604-612.
-
5Tidman M, Sjostrom P, Jones I. A comparison of GFR estimating formulae based upon s-cystatin C and s-creatinine and a combination of the two. Nephrol Dial Transplant, 2008, 23 : 154- 160.
-
6Bokenkamp A, Laarman CARC, Braam KI, et al. Effect of corticosteroid therapy on low-molecular weight protein markers of kidney function. Clin Chem, 2007, 53:2219-2221.
-
7Poge U, Gerhardt TM, Stoffel-Wagner B, et al. Beta-trace protein is an alternative marker for glomerular filtration rate in renal transplantation patients. Clin Chem, 2005, 51 : 1531-1533.
-
8Abbink FC, Laarman CA, Braam KI, et al. Beta-trace protein is not superior to cystatin C for the estimation of GFR in patients receiving corticosteroids. Clin Biochem, 2008, 41:299-305.
-
9White CA, Akbari A, Doucette S, et al. A novel equation to estimate glomerular filtration rate using beta-trace protein. Clin Chem, 2007, 53 : 1965-1968.
-
10Brantsma AH, Bakker SJ, Hillege HL, et al. Cardiovascular and renal outcomes in subjects with K/DOQI stage 1-3 chronic kidney disease : the importance of urinary albumin excretion. Nephrol Dial Transplant, 2008, 23 : 3851-3858.
同被引文献32
-
1National Kidney Foundation.K/DOQI clinical practice guidelines for chronic kidney disease:evaluation,classification,and stratification.Am J Kidney Dis,2002,39(2 Suppl 1):S1-266.
-
2Levey AS,Eckardt KU,Tsukamoto Y,et al.Definition and classification of chronic kidney disease:a position statement from Kidney Disease:Improving Global Outcomes (KDIGO).Kidney Int,2005,67:2089-2100.
-
3Meguid EI,Nahas A,Bello AK.Chronic kidney disease:the global challenge.Lancet,2005,365:331-340.
-
4Couser WG.Chronic kidney disease the promise and the perils.J Am Soc Nephrol,2007,18:2803-2805.
-
5Hallan SI,Ritz E,Lydersen S,et al.Combining GFR and albuminuria to classify CKID improves prediction of ESRD.J Am Soc Nephrol,2009,20:1069-1077.
-
6Zhang L,Zhang P,Wang F,et al.Prevalence and factors associated with CKD:a population study from Beijing.Am J Kidney Dis,2008,51:373-384.
-
7Wen CP,Cheng TY,Tsai MK,et al.All-cause mortality attributable to chronic kidney disease:a prospective cohort study based on 462 293 adults in Taiwan.Lancet,2008,371:2173-2182.
-
8Brantsma AH,Bakker SJ,Hillege HL,et al.Cardiovascular and renal outcome in subjects with K/DOQI stage 1-3 chronic kidney disease:the importance of urinary albumin excretion.Nephrol Dial Transplant,2008,23:3851-3858.
-
9Levey AS,Stevens LA,Schmid CH,et al.A new equation to estimate glomerular filtration rate.Ann Intern Med,2009,150:604-612.
-
10National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease : evaluation, classification, and stratification. Am J Kidney Dis, 2002, 39(2 Suppl 1 ) :S1-266.
引证文献4
-
1王芳,王海燕.慢性肾脏病定义、诊断及分期的新探讨[J].中华内科杂志,2010,49(9):729-730. 被引量:49
-
2孙倩倩,谈敏,常虹.肾小球滤过率在糖尿病患者肾功能评估中的临床价值[J].安徽医科大学学报,2011,46(1):91-94. 被引量:9
-
3李学旺,李航,弓孟春.再解读慢性肾脏病的分期体系[J].中华内科杂志,2011,50(7):541-542. 被引量:4
-
4童薇.中性粒细胞/淋巴细胞和血小板/淋巴细胞比例与糖尿病肾病的相关性研究[J].基层医学论坛,2018,22(28):3936-3937. 被引量:5
二级引证文献67
-
1李学旺,李航,弓孟春.再解读慢性肾脏病的分期体系[J].中华内科杂志,2011,50(7):541-542. 被引量:4
-
2弓孟春,范思远,麦毓麟,李太生.人类免疫缺陷病毒相关性肾脏病的研究进展[J].中华内科杂志,2011,50(7):615-618. 被引量:1
-
3吕波.前列腺电切术治疗高龄患者前列腺增生症105例[J].中国医药科学,2012,2(7):172-172. 被引量:6
-
4徐华庆.生血宁辅助治疗44例血液透析患者肾性贫血疗效观察[J].中国初级卫生保健,2012,26(5):128-129. 被引量:3
-
5曾海飞,何泽云,徐琴,郭志强,张爽爽,陈丽.六味地黄汤对5/6肾切除大鼠肌酐、尿素氮及24h尿蛋白定量的影响[J].湖南中医杂志,2013,29(8):114-116. 被引量:3
-
6郑法雷.慢性肾脏病临床实践中应注意防止分期体系的负面影响[J].中华肾病研究电子杂志,2013,2(1):1-4. 被引量:4
-
7陈学波,胡玉纹.尿毒症维持性血液透析患者C-反应蛋白及营养状态与感染的关系[J].中华医院感染学杂志,2014,24(5):1181-1183. 被引量:21
-
8黄鹤.前列地尔联合黄芪治疗慢性肾功能衰竭的临床观察[J].中国卫生产业,2014,11(6):18-19. 被引量:7
-
9赵敏.人文护理对慢性肾衰行维持性血液透析患者肾功指标及生活质量的影响[J].国际护理学杂志,2019,38(2):223-226. 被引量:15
-
10邵敏,胡永玮.前列地尔与肾康中西医结合治疗对慢性肾功能衰竭患者肾功能及血脂的影响[J].中国综合临床,2014,30(12):1303-1306. 被引量:12
-
1王灵.循证医学的发展对临床护理的启示[J].实用医药杂志,2005,22(11):1022-1022.
-
2王慧平.脑梗塞偏瘫患者的康复护理体会[J].求医问药(下半月),2013(8):255-256. 被引量:1
-
3刘培,吴京秦,段美丽.脓毒症急性肾损伤患者肾功能恢复的影响因素[J].山东医药,2015,55(41):16-19. 被引量:13
-
4赵华,李德春.肝硬化门脉高压患者胆囊结石的手术治疗[J].中国交通医学杂志,2004,18(3):280-281.
-
5李强.硬膜外穿破后的麻醉及处理体会[J].中国中医药咨讯,2012,4(4):527-528.
-
6姜朝晖,方哓明,方旭东,姚宁,龚之舵,盛玉才.肝硬化患者腹腔镜胆囊切除术的体会(附46例报告)[J].中国内镜杂志,2008,14(2):216-216. 被引量:12
-
7万力,钟文旗,柳卫凰,张明华.腹膜透析患者矿物质—骨异常的观察[J].疑难病杂志,2012,11(12):928-930. 被引量:1
-
8安永铸,张振忠,李淑娟,王孝国.要审慎诊断和处理慢性阑尾炎[J].临床误诊误治,1998,11(6):378-378. 被引量:3
-
9孟庆辉,许军,孙备,侯利民,赵金鹏.腹腔镜胆囊切除术741例临床分析[J].哈尔滨医科大学学报,2003,37(1):76-77.
-
10徐刚.纹眉须审慎[J].现代日用科学,2002(4):23-23.